206A.T
PRISM BioLab Co.,LTD
グロース · 医薬品 · 医薬品 · JP
JPY 173.00
+1.17%Margins
Gross margin
39.4%
EBITDA margin
—
EBIT margin
-120.2%
Net margin
-135.5%
FCF margin
-224.1%
-38.0%
Return on equity
-30.9%
Return on assets
-33.7%
Return on invested capital
0.22x
Asset turnover
-JPY 1.5B
Cash from operations
JPY 76
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026